Information Library

Oncology - Product Development & Commercialization

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by:
  • Most Recent
  • Title

  • Targeting Oncology

    June 2, 2010
    Because oncology is not a one-size-fits-all discipline, Quintiles provides fully integrated clinical, commercial, consulting and capital solutions at every stage of a product’s lifecycle so customers can stay focused without missing opportunities.

  • Global Flexibility

    May 9, 2010
    PharmaMar faced a massive logistical challenge. It needed to quickly mobilize an effective sales force covering a market that spans several different national legislations and more than 20 official languages. With the help of Quintiles, on-time recruitment against aggressive timelines made it possible to top 2007 sales goals in the first year.

  • Mapping the Future in Oncology Drug Development

    June 5, 2010
    Improving the development of oncology drugs is a high priority in order to enhance patient outcomes.

  • Commercial – identify, promote and prove treatment value

    April 1, 2010
    Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success.

  • The Power of Consolidation with Functional Resourcing Solutions

    March 31, 2010
    Biopharma companies are outsourcing more clinical trial services for greater cost efficiencies. Quintiles provides integrated services with one point of contact and streamlined management.

  • Mapping the Future in Oncology Drug Development

    March 29, 2010
    Program Chair: Paul Bunn, Jr., MD

  • Integration of Molecular Biomarkers into Clinical Development

    March 29, 2010
    Examining the challenges and opportunities in co-developing a biomarker and drug, this is the first white paper in a new series focusing on oncology.

  • 46th ASCO Annual Meeting 2010

    June 5 - June 7, 2010
    Visit the Quintiles booth: #2053 Mapping the Future in Oncology Drug Development Saturday June 5 – Monday June 7 2010 ASCO Exhibit Hall: Hall A1/A2

  • Biomarker Trends in Breast Cancer Research

    February 24, 2010
    Dr. Hill discusses the implications and questions that will drive future R&D efforts to develop targeted breast cancer therapies.

  • Sub-Saharan Africa Phase II/III Fact Sheet

    July 29, 2009
    Sub-Saharan Africa fact sheet about Phase II/III trials. The gateway to Africa: Access to expanded clinical resources and patient populations in South Africa and beyond.

Page 1 of 2 (13 results)

Subscribe to Email Based on Your Interests

Set preferences